Current
23.3×
5-Year Average
23.0×
All-Time High
48.7×
All-Time Low
7.9×
P/E Ratio daily chart for Labcorp Holdings (LH)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for Labcorp Holdings (LH) from 2001 to 2025
| 2025 | $20.70B | $876.50M | 23.6× | -2.1× | |
| 2024 | $19.17B | $746.00M | 25.7× | -20.5× | |
| 2023 | $19.30B | $418.00M | 46.2× | +32.2× | |
| 2022 | $17.90B | $1.28B | 14.0× | +3.2× | |
| 2021 | $25.72B | $2.38B | 10.8× | -0.1× | |
| 2020 | $17.05B | $1.56B | 11.0× | -6.2× | |
| 2019 | $14.13B | $823.80M | 17.1× | +5.8× | |
| 2018 | $10.88B | $955.70M | 11.4× | +0.3× | |
| 2017 | $14.00B | $1.27B | 11.0× | -4.7× | |
| 2016 | $11.39B | $722.30M | 15.8× | -8.9× | |
| 2015 | $10.76B | $436.10M | 24.7× | +9.3× | |
| 2014 | $7.84B | $511.20M | 15.3× | +3.6× | |
| 2013 | $6.73B | $573.70M | 11.7× | -0.2× | |
| 2012 | $6.96B | $583.10M | 11.9× | -1.9× | |
| 2011 | $7.17B | $519.70M | 13.8× | +0.2× | |
| 2010 | $7.57B | $558.20M | 13.6× | +1.1× | |
| 2009 | $6.79B | $546.30M | 12.4× | -0.4× | |
| 2008 | $5.95B | $464.50M | 12.8× | -2.6× | |
| 2007 | $7.35B | $476.80M | 15.4× | -2.4× | |
| 2006 | $7.70B | $431.60M | 17.9× | +2.2× | |
| 2005 | $6.06B | $386.20M | 15.7× | -0.6× | |
| 2004 | $5.92B | $363.00M | 16.3× | +2.4× | |
| 2003 | $4.47B | $321.00M | 13.9× | +2.6× | |
| 2002 | $2.89B | $254.60M | 11.4× | -15.7× | |
| 2001 | $4.86B | $179.50M | 27.1× | — |
- 202523.6×
- 202425.7×
- 202346.2×
- 202214.0×
- 202110.8×
- 202011.0×
- 201917.1×
- 201811.4×
- 201711.0×
- 201615.8×
- 201524.7×
- 201415.3×
- 201311.7×
- 201211.9×
- 201113.8×
- 201013.6×
- 200912.4×
- 200812.8×
- 200715.4×
- 200617.9×
- 200515.7×
- 200416.3×
- 200313.9×
- 200211.4×
- 200127.1×
About P/E Ratio at Labcorp Holdings (LH)
Labcorp Holdings (LH) P/E ratio is 23.3× as of June 5, 2026. The 5-year average is 23.0×. The sector median currently stands at 25.0×. The current ratio is at the 50th percentile of its own 10-year history.
Labcorp Holdings (LH) historical P/E ratio has ranged from a low of 7.9× (2022) to a high of 48.7× (2025) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Labcorp Holdings P/E Ratio by Year
Labcorp Holdings P/E Ratio 2025: 23.6×
Labcorp Holdings (LH) P/E ratio in 2025 was 23.6×, contracted from 25.7× the prior year.
Labcorp Holdings P/E Ratio 2024: 25.7×
Labcorp Holdings (LH) P/E ratio in 2024 was 25.7×, contracted from 46.2× the prior year.
Labcorp Holdings P/E Ratio 2023: 46.2×
Labcorp Holdings (LH) P/E ratio in 2023 was 46.2×, expanded from 14.0× the prior year.
Labcorp Holdings P/E Ratio 2022: 14.0×
Labcorp Holdings (LH) P/E ratio in 2022 was 14.0×, expanded from 10.8× the prior year.
Labcorp Holdings P/E Ratio 2021: 10.8×
Labcorp Holdings (LH) P/E ratio in 2021 was 10.8×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Labcorp Holdings (LH), ranked by P/E ratio.
| 22.2× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Labcorp Holdings (LH) Key Financials
Charts, filings, and peer comparison for every metric